Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1222, 2008-01, pp. : 25-26
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab: Paradoxical worsening of multiple sclerosis?: case report
Reactions Weekly, Vol. 1, Iss. 1212, 2008-01 ,pp. :
Fingolimod: Multiple sclerosis relapse: case report
Reactions Weekly, Vol. 1, Iss. 1428, 2012-01 ,pp. :
Fingolimod: Multiple sclerosis relapse: case report
Reactions Weekly, Vol. 1, Iss. 1381, 2011-01 ,pp. :
Natalizumab: multiple benefits in multiple sclerosis
Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. :